Allergan, Inc. · Irvine, CA United States (NYSE: AGN)
Key Allergan, Inc. Financials
| Company Type | Public -(NYSE: AGN) Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2011 Sales (mil.) | $5,419.1 |
| 2010 Employees | 9,200 |
Allergan, Inc. Stock Quote (NYSE: AGN)
| Latest 02/15/12 11:26:55 EST | Change ($) | Change (%) | High | Low |
|---|---|---|---|---|
| $88.50 |  -0.385 | -0.430 | $89.05 | $88.37 |
Quotes delayed 15 minutes for NASDAQ, 20 minues for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions. |
Allergan, Inc. Income Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Revenue | 5,419.1 | 4,919.4 | 4,503.6 |
| Cost of Goods Sold | 748.7 | 722.0 | 750.9 |
| Gross Profit | 4,670.4 | 4,197.4 | 3,752.7 |
| Gross Profit Margin | 86.2% | 85.3% | 83.3% |
| SG&A Expense | 2,246.6 | 2,626.8 | 1,921.5 |
| Depreciation & Amortization | 127.6 | 138.0 | 146.3 |
| Operating Income | 1,365.1 | 258.6 | 928.0 |
| Operating Margin | 25.2% | 5.3% | 20.6% |
| Nonoperating Income | (0.5) | (16.4) | (9.6) |
| Nonoperating Expenses | (64.9) | (71.4) | (69.9) |
| Income Before Taxes | 1,299.7 | 170.8 | 848.5 |
| Income Taxes | 361.6 | 165.9 | 224.7 |
| Net Income After Taxes | 938.1 | 4.9 | 623.8 |
| Continuing Operations | 934.5 | 0.6 | 623.8 |
| Discontinued Operations | -- | -- | 0.0 |
| Total Operations | 934.5 | 0.6 | 621.3 |
| Total Net Income | 934.5 | 0.6 | 621.3 |
| Net Profit Margin | 17.2% | 0.0% | 13.8% |
| Diluted EPS from Total Net Income | 3.01 | 0.0 | 2.03 |
| Dividends per Share | 0.20 | 0.20 | 0.20 |
All amounts in millions of US Dollars except per share amounts.
Allergan, Inc. Balance Sheet
| Assets | Dec 11 | Dec 10 | Dec 09 |
| Current Assets | |||
| Cash | 2,406.1 | 1,991.2 | 1,947.1 |
| Net Receivables | 730.6 | 647.3 | 576.6 |
| Inventories | 249.7 | 229.4 | 213.9 |
| Other Current Assets | 661.9 | 1,125.8 | 368.7 |
| Total Current Assets | 4,048.3 | 3,993.7 | 3,106.3 |
| Net Fixed Assets | 807.0 | 800.6 | 808.1 |
| Other Noncurrent Assets | 3,653.3 | 3,513.8 | 3,622.2 |
| Total Assets | 8,508.6 | 8,308.1 | 7,536.6 |
| Liabilities | Dec 11 | Dec 10 | Dec 09 |
| Current Liabilities | |||
| Accounts Payable | 200.4 | 222.5 | 204.0 |
| Short-Term Debt | 83.9 | 670.6 | 18.1 |
| Other Current Liabilities | 670.7 | 635.3 | 589.5 |
| Total Current Liabilities | 955.0 | 1,528.4 | 811.6 |
| Long-Term Debt | 1,515.4 | 1,534.2 | 1,491.3 |
| Other Noncurrent Liabilities | 728.6 | 487.8 | 410.9 |
| Total Liabilities | 3,199.0 | 3,550.4 | 2,713.8 |
| Shareholder's Equity | |||
| Preferred Stock Equity | -- | 0.0 | 0.0 |
| Common Stock Equity | 5,309.6 | 4,757.7 | 4,822.8 |
| Total Equity | 5,309.6 | 4,757.7 | 4,822.8 |
| Shares Outstanding (thou.) | 305,032.0 | 305,525.0 | 304,433.0 |
All amounts in millions of US Dollars except per share amounts.
Allergan, Inc. Cash Flow Statement
| Dec 11 | Dec 10 | Dec 09 | |
| Net Operating Cash Flow | -- | 464 | 1,113 |
| Net Investing Cash Flow | -- | (977.2) | (98.7) |
| Net Financing Cash Flow | 563.0 | (181.5) | |
| Net Change in Cash | 44.1 | 836.7 | |
| Depreciation & Amortization | 127.6 | 138.0 | 146.3 |
| Capital Expenditures | (157.0) | (125.7) | |
| Cash Dividends Paid | (60.6) | (60.6) |
All amounts in millions of US Dollars except per share amounts.